New laser resurfacing therapy promising for actinic keratoses

New laser resurfacing therapy promising for actinic keratoses
For patients with facial photodamage and actinic keratoses, treatment with a new fractional resurfacing technique that uses a 1927-nm nonablative thulium laser reduces the number of facial actinic keratoses and produces noticeable improvement in overall photodamage, according to a study published in the January issue of the Journal of the American Academy of Dermatology.

(HealthDay)—For patients with facial photodamage and actinic keratoses (AK), treatment with a new fractional resurfacing technique that uses a 1927-nm nonablative thulium laser reduces the number of facial AK and produces noticeable improvement in overall photodamage, according to a study published in the January issue of the Journal of the American Academy of Dermatology.

In an effort to evaluate the efficacy, safety, and tolerability of a fractional resurfacing technique that utilizes a nonablative 1927-nm thulium laser, Elliot T. Weiss, M.D., of the Laser & Skin Surgery Center of New York in New York City, and colleagues conducted a six-month prospective study involving 24 individuals with facial photodamage and AK. Patients received up to four treatments at two- to six-week intervals and were evaluated at one, three, and six months after the final treatment.

The researchers found that, at one month after the final treatment, there was a 91.3 percent reduction in the average number of facial AK from baseline (from 14.4 to 1.22). This effect was sustained at three and six months, with 87.3 and 86.6 percent reductions, respectively, in the absolute number of lesions. At six months, a marked or noticeable improvement in overall photodamage was reported.

"The clinical and histologic findings, as well as the reported patient satisfaction and safety, suggest that the of AK and photodamage with a fractionated 1927-nm nonablative thulium laser is a promising new therapeutic option," the authors write.

Two authors are investigators with Solta Medical, manufacturers of the laser used in the study.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Pulsed dye laser effective on port-wine stains in infants

Feb 28, 2012

(HealthDay) -- Pulsed dye laser (PDL) treatment at two-, three-, and four-week intervals is effective for infants with facial port-wine stains (PWS), with minimal short-term side effects, according to a study ...

Dual mode laser therapy effectively treats acne vulgaris

Mar 27, 2012

(HealthDay) -- A series of Nd:YAG laser treatments effectively and rapidly reduces both inflammatory and noninflammatory acne vulgaris lesions, according to a study published in the April issue of the Journal of ...

Recommended for you

New hope for rare disease drug development

7 hours ago

Using combinations of well-known approved drugs has for the first time been shown to be potentially safe in treating a rare disease, according to the results of a clinical trial published in the open access Orphanet Journal of ...

Three weeks since last Ebola case in Mali: WHO

10 hours ago

Mali has not had a case of Ebola for three weeks, the World Health Organization said Wednesday, completing one of the two incubation periods the country needs to be declared free of the virus.

Migraine may double risk for facial paralysis

11 hours ago

Migraine headache may double the risk of a nervous system condition that causes facial paralysis, called Bell's palsy, according to a new study published in the December 17, 2014, online issue of Neurology, the medical journa ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.